Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension

Csaba P. Kovesdy, Lawrence J. Appel, Morgan E. Grams, Lisa Gutekunst, Peter A. McCullough, Biff F. Palmer, Bertram Pitt, Dominic A. Sica, Raymond R. Townsend

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

While much emphasis, and some controversy, centers on recommendations for sodium intake, there has been considerably less interest in recommendations for dietary potassium intake, in both the general population and patients with medical conditions, particularly acute and chronic kidney disease. Physiology literature and cohort studies have noted that the relative balance in sodium and potassium intakes is an important determinant of many of the sodium-related outcomes. A noteworthy characteristic of potassium in clinical medicine is the extreme concern shared by many practitioners when confronted by a patient with hyperkalemia. Fear of this often asymptomatic finding limits enthusiasm for recommending potassium intake and often limits the use of renin-angiotensin-aldosterone system blockers in patients with heart failure and chronic kidney diseases. New agents for managing hyperkalemia may alter the long-term management of heart failure and the hypertension, proteinuria, and further function loss in chronic kidney diseases. In this jointly sponsored effort between the American Society of Hypertension and the National Kidney Foundation, 3 panels of researchers and practitioners from various disciplines discussed and summarized current understanding of the role of potassium in health and disease, focusing on cardiovascular, nutritional, and kidney considerations associated with both hypo- and hyperkalemia.

Original languageEnglish (US)
JournalAmerican Journal of Kidney Diseases
DOIs
StateAccepted/In press - 2017

Fingerprint

Hyperkalemia
Potassium
Homeostasis
Chronic Renal Insufficiency
Kidney
Education
Sodium
Health
Heart Failure
Dietary Potassium
Hypokalemia
Clinical Medicine
Renin-Angiotensin System
Proteinuria
Fear
Cohort Studies
Research Personnel
Hypertension
Population

Keywords

  • Cardiovascular disease (CVD)
  • Chronic kidney disease (CKD)
  • Dietary intake
  • Heart disease
  • Hyperkalemia
  • Hypokalemia
  • Patiromer calcium (RLY5016)
  • Potassium
  • Potassium homeostasis
  • Potassium secretion
  • Renal excretion
  • Review
  • Sodium zirconium cyclosilicate (ZS-9)
  • Sodium-polystyrene sulfonate

ASJC Scopus subject areas

  • Nephrology

Cite this

Potassium Homeostasis in Health and Disease : A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension. / Kovesdy, Csaba P.; Appel, Lawrence J.; Grams, Morgan E.; Gutekunst, Lisa; McCullough, Peter A.; Palmer, Biff F.; Pitt, Bertram; Sica, Dominic A.; Townsend, Raymond R.

In: American Journal of Kidney Diseases, 2017.

Research output: Contribution to journalArticle

Kovesdy, Csaba P. ; Appel, Lawrence J. ; Grams, Morgan E. ; Gutekunst, Lisa ; McCullough, Peter A. ; Palmer, Biff F. ; Pitt, Bertram ; Sica, Dominic A. ; Townsend, Raymond R. / Potassium Homeostasis in Health and Disease : A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension. In: American Journal of Kidney Diseases. 2017.
@article{19ccf2916a9c49558df61829251c5fcb,
title = "Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension",
abstract = "While much emphasis, and some controversy, centers on recommendations for sodium intake, there has been considerably less interest in recommendations for dietary potassium intake, in both the general population and patients with medical conditions, particularly acute and chronic kidney disease. Physiology literature and cohort studies have noted that the relative balance in sodium and potassium intakes is an important determinant of many of the sodium-related outcomes. A noteworthy characteristic of potassium in clinical medicine is the extreme concern shared by many practitioners when confronted by a patient with hyperkalemia. Fear of this often asymptomatic finding limits enthusiasm for recommending potassium intake and often limits the use of renin-angiotensin-aldosterone system blockers in patients with heart failure and chronic kidney diseases. New agents for managing hyperkalemia may alter the long-term management of heart failure and the hypertension, proteinuria, and further function loss in chronic kidney diseases. In this jointly sponsored effort between the American Society of Hypertension and the National Kidney Foundation, 3 panels of researchers and practitioners from various disciplines discussed and summarized current understanding of the role of potassium in health and disease, focusing on cardiovascular, nutritional, and kidney considerations associated with both hypo- and hyperkalemia.",
keywords = "Cardiovascular disease (CVD), Chronic kidney disease (CKD), Dietary intake, Heart disease, Hyperkalemia, Hypokalemia, Patiromer calcium (RLY5016), Potassium, Potassium homeostasis, Potassium secretion, Renal excretion, Review, Sodium zirconium cyclosilicate (ZS-9), Sodium-polystyrene sulfonate",
author = "Kovesdy, {Csaba P.} and Appel, {Lawrence J.} and Grams, {Morgan E.} and Lisa Gutekunst and McCullough, {Peter A.} and Palmer, {Biff F.} and Bertram Pitt and Sica, {Dominic A.} and Townsend, {Raymond R.}",
year = "2017",
doi = "10.1053/j.ajkd.2017.09.003",
language = "English (US)",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Potassium Homeostasis in Health and Disease

T2 - A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension

AU - Kovesdy, Csaba P.

AU - Appel, Lawrence J.

AU - Grams, Morgan E.

AU - Gutekunst, Lisa

AU - McCullough, Peter A.

AU - Palmer, Biff F.

AU - Pitt, Bertram

AU - Sica, Dominic A.

AU - Townsend, Raymond R.

PY - 2017

Y1 - 2017

N2 - While much emphasis, and some controversy, centers on recommendations for sodium intake, there has been considerably less interest in recommendations for dietary potassium intake, in both the general population and patients with medical conditions, particularly acute and chronic kidney disease. Physiology literature and cohort studies have noted that the relative balance in sodium and potassium intakes is an important determinant of many of the sodium-related outcomes. A noteworthy characteristic of potassium in clinical medicine is the extreme concern shared by many practitioners when confronted by a patient with hyperkalemia. Fear of this often asymptomatic finding limits enthusiasm for recommending potassium intake and often limits the use of renin-angiotensin-aldosterone system blockers in patients with heart failure and chronic kidney diseases. New agents for managing hyperkalemia may alter the long-term management of heart failure and the hypertension, proteinuria, and further function loss in chronic kidney diseases. In this jointly sponsored effort between the American Society of Hypertension and the National Kidney Foundation, 3 panels of researchers and practitioners from various disciplines discussed and summarized current understanding of the role of potassium in health and disease, focusing on cardiovascular, nutritional, and kidney considerations associated with both hypo- and hyperkalemia.

AB - While much emphasis, and some controversy, centers on recommendations for sodium intake, there has been considerably less interest in recommendations for dietary potassium intake, in both the general population and patients with medical conditions, particularly acute and chronic kidney disease. Physiology literature and cohort studies have noted that the relative balance in sodium and potassium intakes is an important determinant of many of the sodium-related outcomes. A noteworthy characteristic of potassium in clinical medicine is the extreme concern shared by many practitioners when confronted by a patient with hyperkalemia. Fear of this often asymptomatic finding limits enthusiasm for recommending potassium intake and often limits the use of renin-angiotensin-aldosterone system blockers in patients with heart failure and chronic kidney diseases. New agents for managing hyperkalemia may alter the long-term management of heart failure and the hypertension, proteinuria, and further function loss in chronic kidney diseases. In this jointly sponsored effort between the American Society of Hypertension and the National Kidney Foundation, 3 panels of researchers and practitioners from various disciplines discussed and summarized current understanding of the role of potassium in health and disease, focusing on cardiovascular, nutritional, and kidney considerations associated with both hypo- and hyperkalemia.

KW - Cardiovascular disease (CVD)

KW - Chronic kidney disease (CKD)

KW - Dietary intake

KW - Heart disease

KW - Hyperkalemia

KW - Hypokalemia

KW - Patiromer calcium (RLY5016)

KW - Potassium

KW - Potassium homeostasis

KW - Potassium secretion

KW - Renal excretion

KW - Review

KW - Sodium zirconium cyclosilicate (ZS-9)

KW - Sodium-polystyrene sulfonate

UR - http://www.scopus.com/inward/record.url?scp=85030772462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030772462&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2017.09.003

DO - 10.1053/j.ajkd.2017.09.003

M3 - Article

C2 - 29029808

AN - SCOPUS:85030772462

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

ER -